The herpes simplex virus 1 (HFEM) mutant tsB7 failed to express any detectable viral polypeptides and did not significantly inhibit host cell protein synthesis in infected cells maintained at the nonpermissive temperature. The mutant could complement the growth of a coinfecting temperature-sensitive mutant virus differing in plaque phenotype and thus appeared capable of penetrating doubly infected cells. The yield of tsB7 was enhanced by the coinfecting virus but not to the extent that the coinfecting virus was enhanced. Coinfection studies suggested that the tsB7 defect was complemented in trans, but poorly, by the wild-type parent and other viruses. Marker rescue of tsB7 by transfection with herpes simplex virus 2 XbaI DNA fragments mapped the mutation between 0.45 and 0.70 map units. Analysis of the DNA structure of the ts+ intertypic recombinants generated by this rescue showed that the herpes simplex virus 2 DNA substitutions all contained the region between 0.46 and 0.52 map units, thus further defining the map position of the mutation. Analyses of the polypeptides expressed by these intertypic recombinants defined the genome location of the genes specifying polypeptides 2, 6, 10, 32, 43, and 44 and indicated that the mutation maps in or near genes coding for virion structural polypeptides. This region of the genome is represented as stable transcripts and cytoplasmic mRNA only after viral DNA replication (P. C. Jones and B. Roizrnan, J. Virol. 31:299-314, 1979), and thus this gene appears to be a late function. These results are consistent with the ts mutation in tsB7 being in a gene coding for a virion component which functions before expression of the alpha genes early in infection. The most likely explanation is that the mutant is blocked at a stage of uncoating and the defect is complemented, although poorly, by a coinfecting virus gene product.
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In this paper, we report on the characteristics of the herpes simplex virus 1 (HSV-1) temperature-sensitive mutant tsB7. This mutant fails to produce any detectable viral polypeptides and has no appreciable long-term effect on the synthesis of host proteins at the nonpermissive temperature. Pertinent to this report are the following.
(i) HSV-1 and herpes simplex virus 2 (HSV-2) are genetically closely related (14) . Both HSV-1 and HSV-2 specify approximately 50 polypeptides (12, 23) which form at least three groups whose synthesis is coordinately regulated and sequentially ordered in a cascade fashion (12, 25) . The a polypeptides made immediately after infection of permissive cells with HSV-1 attain peak rates of synthesis between 2 and 4 h postinfection and require no viral protein synthesis for the synthesis and processing of their mRNA. These polypeptides are required for the synthesis of, polypeptides, and these in turn shut off the synthesis of a polypeptides; the ,B polypeptides are involved in the synthesis of viral DNA and induce the synthesis of structural y polypeptides.
(ii) In the course of their replication, herpes simplex viruses shut off the synthesis of host proteins and DNA and reduce the synthesis of host RNA (22, 29, 30) . The shutoff of the synthesis of host proteins appears to occur in two stages. The first occurs immediately after infection and is mediated by a structural protein inasmuch as it does not require the transcription of the viral genome (6) . The second stage requires the expression of viral protein and appears to coincide with the synthesis of J8 poly-539 peptides (12, 21) . In general, HSV-2 isolates inhibit host protein synthesis more rapidly and more completely than HSV-1 during the first stage of inhibition of host macromolecular synthesis (2, 22) . Analysis of HSV-1 x HSV-2 intertypic recombinants showed that the HSV-2 gene(s) responsible for the accelerated shutoff of host protein synthesis maps between 0.52 and 0.59 map units (5, 20) . MATERIALS 
AND METHODS
Viruses. The isolation and properties of HSV-2 (G) and HSV-1 (HFEM) ts+ syn are described in references 4 and 9, respectively. HSV-1 (HFEM) tsB7 syn+ was isolated by bromodeoxyuridine mutagenesis of HSV-1 (HFEM)-infected cells. HFEM originally contained a mixture of syn and syn+ viruses, and the tsB7 mutant apparently arose from a syn+ virus. HSV-1 (F) is a primary isolate used extensively in the Chicago laboratory and has been passaged no more than four times in cell culture at 340C (4, 11) . We have found that this strain replicates poorly at 39°C and that the efficiency of plating at 390C relative to 34°C is less than l0'. It does replicate well at 370C, as its efficiency of plating at 370C relative to 34°C is 0.5. This phenotype is not unusual for fresh isolates of HSV-1, since many other isolates tested showed similar properties (D. M. Knipe and B. Roizman, unpublished observations). The temperature-sensitive marker in HSV-1 (F) maps in the repeated sequences of the S component, 0.83 to 0.865 and 0.965 to 1.0 map units (P. J. Godowski and D. M. Knipe, unpublished data). The virus expresses largely a polypeptides at 39°C, and therefore the wild-type HSV-1 (F) strain produces a temperature-sensitive a product similar to those of ts mutants in complementation group [1] [2] (28) .
HSV-1 (F) ts502 synl,2 is the designation of a recombinant produced by marker transfer of the syn loci from HSV-1 (1061) to HSV-1 (F) (27) . At the permissive temperature it fuses both HEp-2 and Vero cells.
Virus stocks were prepared and titrated in Vero cell cultures. The infected cells were maintained in medium 199 supplemented with 1% inactivated calf serum.
Complementation tests. Complementation tests were performed by a modification of the procedure of Schaffer et al. (28) . After addition of virus to the cultures, the flasks were submerged in a 390C water bath or a 390C convection incubator. After the 1-h absorption period, the virus inoculum was removed and 5 ml of medium 199-1% inactivated calf serum was added. After 18 h of incubation, the virus was harvested and titrated. Equivalent results were obtained in experiments in which the cells were or were not washed at the end of the absorption period.
Marker rescue mapping. Mapping of the ts lesion in tsB7 was performed by the cotransfection of mutant DNA and individual fragments of HSV-2 (G) DNA generated by cleavage of the DNA with XbaI restriction endonuclease (6, 15) . The flasks were incubated for 3 to 4 days at 340C, and the progeny virus was harvested and titrated at 34 and 390C. The rescued ts+ clones were isolated by four cycles of plaque purification under agarose overlay at 390C (19) .
Purification of viral DNA and analysis of recombinant genomes. Viral DNA for the marker rescue studies and for analysis of recombinant genomes was purified by Nal density gradient centrifugation of infected cell extracts (31) . HsuI, BgllI, XbaI, and HpaI restriction endonucleases were prepared as described previously (19) . BamHI and KpnI restriction endonucleases were purchased from New England Biolabs.
Analysis of polypeptides in infected and mockinfected cells. Cells were labeled with L-U-'4C-labeled amino acids (leucine, isoleucine, and valine) at times specified in the text and under conditions described by Morse et al. (20) . At the end of the labeling interval, the cells were harvested, disrupted with sodium dodecyl sulfate, and subjected to electrophoresis in polyacrylamide slab gels as described (20) . showed a 100-fold increase in the yield of syn plaques (ts502 marker) and a twofold increase in the syn+ plaques (tsB7 marker) relative to the singly infected cultures ( The observation that in the complementation test the increase in titer of ts502 was greater than the increase in the tsB7 titer raised the possibility that tsB7 contained a cis-acting mutation that causes it to replicate poorly. To examine this question, we first coinfected cells with tsB7 and ts502 at 340C and examined the progThe infected cellpolypeptides were numbered according to the nomenclature published elsewhere (12, 20) . Under these conditions of infection, the progeny contained approximately equal amounts of the two infecting viruses. The mutant tsB7 appeared to have a partial cis-acting phenotype, although it could apparently be complemented by coinfecting viruses. As discussed further below, a partial complementation of an uncoating mutant would give a partial cis-acting mutant phenotype.
RESULTS

Replication
Marker rescue of tsB7 with HSV-2 DNA fragments. The genome location of the ts lesion in tsB7 was determined by the cotransfection method of marker rescue (16) . In these experi- ments, cell cultures were cotransfected with tsB7 DNA and individual XbaI restriction endonuclease fragments of HSV-2 (G) DNA (Fig. 2) . After 3 to 4 days of incubation at 340C, the progeny virus was harvested and assayed at 34 and 390C (Table 3 ). The most efficient rescue was obtained with the XbaI-D fragment, mapping from 0.45 to 0.71 map units. To further characterize the site ofthe recombinational events, six recombinants produced by marker rescue with HSV-2 (G) DNA were analyzed with respect to the domains of the HSV-2 DNA substituted in the recombinants. The results ( Fig. 3 and 4) were as follows.
(i) The recombinant RB7G1 contained no detectable HSV-2 sequences (Fig. 3) and expressed no polypeptides which comigrated with HSV-2 polypeptides (Fig. 4) . Thus, RB7G1 was either a revertant or a recombinant containing too small a replacement of HSV-1 sequences to be detected.
(ii) The recombinant RB7G2 retained the HSV-1 EcoRI-M-O and the HpaI-F-E cleavage sites but lost all intervening HSV-1 cleavage sites. Therefore, the maximal left boundary of the recombinational event was the HSV-1 EcoRI-M-O cleavage site, and the minimal left boundary was the HSV-1 HpaI-B-H cleavage site. The maximal right boundary was the HSV-1 HpaI-E-F cleavage site, and the minimal right boundary was the BamHI-O-I cleavage site (Fig.  3) . This recombinant expressed the ICP2, -6, -43, -44, -10, and -32 of HSV-2 (Fig. 4) .
(iii) The recombinant RB7G3 retained the HSV-1 EcoRI-O-L cleavage site and the BamHI-O-I cleavage site but lost all intervening HSV-1 cleavage sites. The maximal left boundary was the HSV-1 EcoRI-O-L cleavage site, and the minimal left boundary was the EcoRI-L-A cleavage site. The maximal right boundary was the HSV-1 BamHI-O-I cleavage site, and the minimal right boundary was the HSV-2 HpaI-D-E cleavage site. This recombinant specified the HSV-2 ICP10 (Fig. 4) .
(iv) The recombinants RB7G4 and RB7G5 retained the HSV-1 EcoRI-M-O cleavage site and the HSV-1 BamHI-D-H cleavage site but lost all intervening HSV-1 cleavage sites. Therefore, the maximal left boundary of the recombinational events was the EcoRI-O-L cleavage site, and the minimal left boundary was the HSV-1 HpaI B-H cleavage site. The maximal right boundary was the BamHI cleavage site, and the minimal right boundary was the HSV-1 EcoRI-L-A cleavage site. These recombinants gained one new KpnI cleavage site consistent with the position of the HSV-2 KpnI-G-D cleavage site. These recombinants expressed the HSV-2 ICP2, -43, and -44 (Fig. 4) .
(v) The recombinant RB7G6 retained the HSV-1 HpaI-B-H and HpaI-F-E cleavage sites but lost all intervening HSV-1 cleavage sites. The maximal left boundary was the HSV-1 HpaI-B-H cleavage site, and the miniimal left boundary was the HSV-1 EcoRI-L-A cleavage site. The maximal right boundary was the HpaI-F-E cleavage site, and the minimal right boundary was the HSV-1 BamHI-O-I cleavage site. This recombinant expressed the HSV-2 ICP6, -10, and -32 (Fig. 4) .
In summary, the region of HSV-2 DNA replacement common to all recombinants was the region between the HSV-1 EcoRI-O-L cleavage site and the BamHI-D-H cleavage site, or map positions 0.46 to 0.52. This further defines the map position of the ts mutation in tsB7. The maximal boundaries for the type-specific determinants of the polypeptides were ICP2, -43, and -44 (the EcoRI-M-O cleavage site to the EcoRI-L-A cleavage site); ICP10 (the EcoRI-L-A cleavage site to the BamHI-O-I cleavage site); and ICP6 and -32 (the HSV-2 HpaI-D-E cleavage site to the HSV-1 HpaI-F-E cleavage site). The ts mutation in tsB7 was also closely linked to the ICP10 type-specific determinant (three of seven recombinants) and the ICP2, -43, and -44 type-specific determinants (three of seven recombinants). DISCUSSION We have presented evidence that the mutant HSV-1 (HFEM) tsB7 expresses no detectable viral polypeptides and does not significantly inhibit host cell protein synthesis in infected cells maintained at the nonpermissive temperature. Furthermore, the mutant can complement the growth of a coinfecting virus. Thus, the mutant viral genome can penetrate doubly infected cells. The block at the nonpermissive temperature appears to occur after entry of the virus into the host cell and before the expression of the alpha gene products.
Complementation studies with tsB7. The mutant tsB7 was clearly shown to be capable of complementing the replication of a coinfecting temperature-sensitive mutant which maps within the region of the genome encoding ICP4 (Godowski and Knipe, unpublished data) and which expresses largely alpha proteins at the nonpermissive temperature (L. Pereira and B. Roizman, unpublished data). Therefore, in order for tsB7 to complement ts502, tsB7 must express ICP4. Because tsB7 does not express ICP4 in singly infected cells at any detectable level, it appears that ts502 must supply the defective gene function in order for tsB7 to express ICP4. The mutated tsB7 gene function must be (at least in part) a trans-acting gene product. However, we observed that the yield of tsB7 was always lower than the yield of the coinfecting virus when cells were infected at 390C. There- fore, it appears that the mutation in tsB7 is partially cis-acting in nature; i.e., the mutation cannot be fully complemented by a coinfecting virus. It should be noted that a defect in uncoating which is partially complemented by a coinfecting virus would give reduced yields of the mutant virus defective in uncoating because the effective number of genomes participating in replication would be less for the uncoating mutant. Because of the time of the block in replication in tsB7-infected cells, a defect in uncoating of the tsB7 genome inside infected cells is a possible explanation for the mutant defect. An alternative explanation that we cannot rule out completely at the present time is that a very small, undetectable amount of early proteins is made from the tsB7 genome which can complement the growth of ts502. If the block in replication of tsB7 were in uncoating, this explanation would also lead to higher yields of ts502 than tsB7.
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classes of viral mutants that show a complete lack of viral gene expression under nonpernissive conditions, i.e., the ts3 mutant of polyoma virus (3), the tsD mutants of simian virus 40 (24) , and the group I host range mutants of adenovirus (1, 10) . The simian virus 40 and polyoma mutants map in the late region of the genome (8, 17) and appear to be defective in uncoating of the viral DNA (3, 24) . Therefore, the DNA of these mutants cannot be transcribed to yield early mRNA. These mutants are unable to complement other coinfecting mutants, and thus this uncoating function is a cis-acting function (3). The group I host range mutants of adenovirus map in the early region I of the viral genome, and only the mRNA's for that specific region are expressed from the mutant genome in nonpermissive cells (1, 7) . This appears to be a "preearly" gene function whose synthesis is needed for expression of the early genes. The mutation of tsB7 differs from these because it can be complemented by other viruses, and the existing evidence strongly argues that the a gene products require no prior viral protein synthesis (12, 13) . Several different inhibitors of alpha protein synthesis have been used to allow accumulation of a mRNA. There is no evidence to suggest that a "pre-early" protein gene product must be synthesized before expression of the a genes.
Map position of the ts mutation of tsB7. The marker rescue mapping of the ts mutation of tsB7 by analysis of intertypic recombinants determined the map position of the lesion to be within 0.46 to 0.52 map units. This location has been confirmed by fme-structure mapping using cloned HSV-1 (F) DNA fragments (Batterson and Roizman, work in progress). Therefore, the ts mutation seems likely to map in this region of the viral DNA. This region of the genome is represented in stable cytoplasmic mRNA only after viral DNA replication (13) . It therefore seems likely that the tsB7 mutation is within a gene expressed after DNA replication. Furthermore, because most of the genes expressed after DNA replication code for virion structural polypeptides, it also seems likely that the tsB7 lesion is within a structural polypeptide gene.
We have used the intertypic recombinants generated by rescue of tsB7 with HSV-2 DNA to determine the viral polypeptides encoded near the tsB7 lesion. None of the viral polypeptides which show type-specific mobilities on polyacrylamide gels correlated exactly with the tsB7 lesion; thus, none can be said to contain the lesion. However, the type-specific determinants for ICP2, -10, -43, and -44 were transferred along with the rescuing sequences in three of the seven recombinants analyzed. Thus, the genes for these proteins are closely linked to the tsB7 locus.
As indicated in the beginning of this paper, the shutoff of host protein and DNA synthesis occurs in two stages. The mutant tsB7 did not significantly inhibit host cell protein synthesis as assayed by the pattern of host cell proteins displayed on polyacrylamide gels. In addition to the experiments cited in the text, other experiments involving infection of sparsely seeded cell cultures incubated at the nonpermissive temperature indicated that the infected cells were able to multiply for at least 3 days, but that subsequent shiftdown to the permissive temperature resulted in the destruction ofthe cells (Batterson and Roizman, work in progress). Thus, the effect on the cells of infection with tsB7 at the nonpermissive temperature seems to be minimal. Previous studies have mapped the accelerated shutoff by HSV-2 virions to the region between 0.52 and 0.79 map units (5, 20) or near the tsB7 lesion. Therefore, it is conceivable that the two functions are encoded within the same gene. It is still unclear whether the lack of host shutoff by tsB7 is due to the lack of expression of viral gene products in cells infected at the nonpermissive temperature. Thus, we cannot determine at this time whether the two functions are within the same gene, whether they are in different genes and both are lost by tsB7, or whether the two functions are in different genes and only one is lost by tsB7. Further studies are in progress to discriminate among these possibilities.
Nature of the tsB7 defective gene product. The current evidence suggests that the defective gene product in tsB7 is a virion component that can be complemented by a gene product contributed by another coinfecting virus. This gene product could act upon the tsB7 capsid to uncoat the viral DNA or to allow it to express the a genes. Alternatively, it could alter the host RNA polymerase so that it can transcribe the viral genome efficiently. These functions would be required only for infections initiated by virions because it is known that rigorously deproteinized HSV is infectious, albeit at lower efficiencies than virions. Therefore the tsB7 gene function appears to be a late viral gene product that functions early in the viral replication cycle.
